The content at ACR Orlando was vast. I looked at several posters/listened to many talks and heard from colleagues. Here is my list TOP 6 practice changing themes.
The last day of ACR 2026 was a half-day but a busy day, with several exciting reports, especially coming from the late-breaking abstracts.
#Dazodolibep #RCT in #SjD #CD40Li fusion protein no Fc 3 arms - 2 protocols ⬆️signs #ESSDAI>5. Entered >10 Other ⬆️#ESSPRI #Sjogren’s 1 or 2ndary (25%) 93%F -1.8 diff from PBO +results #ACRbest new Rx! #LB22 #ACR26 #ACRbest @RheumNow @ACRheum https://t.co/JJaDp0nCnM
Mariette et al. NECESSITY trial in primary Sjogren's disease. New response measure (STAR). Responders at W24 was 24.3% with placebo, 54.4% with HCQ + MMF (p< 0.001) and 52.4% with HCQ + LEF (p< 0.001). @RheumNow #ACR26 Abstr#LB15 #ACRbest https://t.co/sIQcC3KKSD
